IRE1beta: A Novel Pathway for Regulation of Airway Epithelial Mucin Production

IRE1beta:调节气道上皮粘蛋白产生的新途径

基本信息

项目摘要

DESCRIPTION (provided by applicant): Airway inflammatory diseases such as asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF) are characterized by mucous cell metaplasia and mucus overproduction. This application addresses a central issue in the pathogenesis of these diseases by investigating a novel mechanism responsible for the overproduction of mucins during airway inflammation. Inflammation of human bronchial epithelia (HBE) activates the unfolded protein response (UPR). The UPR activation couples to stimulation of the inositol requiring enzyme 1 (IRE1), an ER enzyme that activates the transcription factor X-box binding protein 1 (XBP-1), the canonical IRE1-dependent pathway required for protein secretion in many cells. Although recent studies have shown that activation of the IRE1/XBP-1 pathway is functionally relevant for airway epithelial inflammation-mediated cytokine secretion in vitro and in vivo, the role of IRE1 signaling in mucin production during airway inflammation has not been investigated. Because IRE1 can also activate JNK and p38 MAP kinases and NF-?B (non-canonical IRE1 pathways), and their activation can induce mucin transcription, IRE1 might also be functionally relevant for mucin production. IRE1 exists in two isoforms, 1 and 2. We found that IRE1a was ubiquitously expressed, but IRE1¿ was present only in gut and respiratory epithelia. While IRE1¿ expression was > 30 fold higher than IRE1a expression in HBE, IRE1¿ was absent in primary human alveolar type II cells. Moreover, a strong correlation between IRE1¿2 and MUC5B expression was found during HBE differentiation. In mouse tissues, IRE1¿ was absent in lung parenchyma but its expression was 6.5-8.5 fold higher than IRE1a expression in nasopharynx, trachea, and bronchus, tissues that exhibit higher levels of mucous cells. In wild-type (wt) mice, IRE1¿ was expressed in Clara cells and ovalbumin (OVA)-induced mucous cells, but was absent in ciliated cells, suggesting a specific function for IRE1¿ related to mucin production. OVA-increased airway epithelial Muc5b and Muc16 production was blunted in IRE1¿-/- vs. wt mice. Further evidence for a key functional role of IRE1¿ in mucin production was given by a strong correlation between IRE1¿ and genes involved in mucin production or glycosylation. Our Specific Aims will test the primary hypothesis that IRE1¿ is required for mucin production by airway mucous cells, it stimulates mucin transcription and/or regulates genes involved in mucin production or glycosylation, its action is distinct from IRE1a action, and knocking out IRE1¿ will reduce mucin overproduction in models relevant for human airways inflammatory disease. Studies will utilize in vitro and in vivo models of airway inflammation characterized by mucous cell metaplasia and mucin overproduction. Primary cultures of wt and IRE1¿-/- murine airway epithelia, primary cultures of HBE expressing different levels of IRE1¿, and the Scnn1b mouse exhibiting deletion of IRE1¿ in airway epithelia will be used to test the role of IRE1¿ in mucin production. These novel studies may have a high impact by revealing IRE1¿ as a therapeutic target for asthma, COPD, and CF airways disease. PUBLIC HEALTH RELEVANCE: Mucin overproduction characterizes many airway inflammatory diseases. Our studies will test the functional role of IRE1¿, a protein involved in endoplasmic reticulum stress responses, in mucin production associated with airway inflammation and may lead to new therapies for asthma, COPD and CF patients.
描述(由应用提供):气道炎症性疾病,例如哮喘,慢性阻塞性肺疾病(COPD)和囊性纤维化(CF),其特征是粘液细胞化生和粘膜过量产生。该应用程序通过研究导致气道炎症期间粘蛋白过量生产的新机制来解决这些疾病发病机理的核心问题。人支气管上皮(HBE)的炎症激活了展开的蛋白质反应(UPR)。 UPR激活夫妇刺激需要酶1(IRE1)的肌醇,这是一种激活转录因子X-box结合蛋白1(XBP-1)的ER酶,这是许多细胞中蛋白质分泌所需的典型IRE1依赖性途径。尽管最近的研究表明,IRE1/XBP-1途径的激活在功能上与气道上皮炎症介导的体外和体内细胞因子分泌有关,但尚未研究IRE1信号在粘蛋白注射过程中的粘蛋白产生中的作用。因为IRE1还可以激活JNK和p38 MAP激酶和NF-?B(非经典IRE1途径),并且它们的激活可以诱导粘蛋白转录,因此IRE1也可能在功能上与粘蛋白产生有关。 IRE1 exists in two isoforms, 1 and 2. We found that IRE1a was ubiquitously expressed, but IRE1¿ While IRE1¿ expression was > 30 fold higher than IRE1a expression in HBE, IRE1¿ In mouse tissues, IRE1¿2 In wild-type (wt) mice, IRE1¿ was expressed in Clara cells and ovalbumin (OVA)-induced mucous cells, but was纤毛细胞中没有,这表明IRE1的特定功能与粘蛋白的产生有关。在IRE1�与WT小鼠中,OVA增强的气道上皮MUC5B和MUC16的产生被钝化。 IRE1在粘蛋白产生中具有关键功能作用的进一步证据是通过IRE1与粘蛋白产生或糖基化涉及的基因之间的强相关性给出的。我们的具体目的将检验一个主要的假设,即IRE1¿是通过气道粘液细胞产生粘蛋白所必需的,它刺激粘蛋白转录和/或调节与粘蛋白产生或糖基化有关的基因,其作用与IRE1A的作用不同,而IRE1损坏IRE1€将减少对人类空气中的粘液生产的粘液过度生产。研究将利用以粘液细胞化学和粘蛋白过量生产为特征的气道炎症体内和体内模型。 WT和IRE1�的原发性培养物 - / - 鼠气上皮,HBE表达不同水平IRE1¿的原发性培养物以及在气道上皮中表现出IRE1的SCNNN1B小鼠将用于测试IRE1在粘蛋白产生中的作用。这些新的研究可能会通过揭示IRE1€作为哮喘,COPD和CF气道疾病的治疗靶点而产生很大的影响。 公共卫生相关性:粘蛋白过量生产特征许多气道炎症性疾病。我们的研究将测试IRE1¿的功能作用,IRE1¿是一种参与内质网应激反应的蛋白质,在与气道注射相关的粘蛋白产生中,并可能导致哮喘,COPD和CF患者的新疗法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Carla Maria Pedrosa Ribeiro其他文献

Carla Maria Pedrosa Ribeiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Carla Maria Pedrosa Ribeiro', 18)}}的其他基金

Pre-Clinical Evaluation of IRE1beta as a Novel Therapeutic Target for Cystic Fibrosis Airway Mucus Production
IRE1beta 作为囊性纤维化气道粘液产生的新治疗靶点的临床前评估
  • 批准号:
    10296058
  • 财政年份:
    2021
  • 资助金额:
    $ 18.5万
  • 项目类别:
Pre-Clinical Evaluation of IRE1beta as a Novel Therapeutic Target for Cystic Fibrosis Airway Mucus Production
IRE1beta 作为囊性纤维化气道粘液产生的新治疗靶点的临床前评估
  • 批准号:
    10675710
  • 财政年份:
    2021
  • 资助金额:
    $ 18.5万
  • 项目类别:
IRE1beta: A Novel Pathway for Regulation of Airway Epithelial Mucin Production
IRE1beta:调节气道上皮粘蛋白产生的新途径
  • 批准号:
    7960927
  • 财政年份:
    2010
  • 资助金额:
    $ 18.5万
  • 项目类别:

相似国自然基金

Transgelin-2与Ezrin蛋白结合介导针刺抗哮喘舒张气道平滑肌效应机制研究
  • 批准号:
    82274646
  • 批准年份:
    2022
  • 资助金额:
    52.00 万元
  • 项目类别:
    面上项目
Transgelin-2与Ezrin蛋白结合介导针刺抗哮喘舒张气道平滑肌效应机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
钙结合蛋白S100A4通过TLR-4信号轴调控过敏性哮喘肥大细胞与嗜酸性粒细胞相互作用及机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
钙结合蛋白S100A4通过TLR-4信号轴调控过敏性哮喘肥大细胞与嗜酸性粒细胞相互作用及机制研究
  • 批准号:
    82201968
  • 批准年份:
    2022
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
基于高效模拟设计的抗哮喘靶标蛋白TG2激动剂的发现优化
  • 批准号:
    81872797
  • 批准年份:
    2018
  • 资助金额:
    57.0 万元
  • 项目类别:
    面上项目

相似海外基金

Vagal airway sensory nerve activation by beta-coronavirus spike protein
β-冠状病毒刺突蛋白激活迷走神经气道感觉神经
  • 批准号:
    10748485
  • 财政年份:
    2023
  • 资助金额:
    $ 18.5万
  • 项目类别:
Effect of TL1A on Th9 cell Polarization and Pathogenicity
TL1A 对 Th9 细胞极化和致病性的影响
  • 批准号:
    10607105
  • 财政年份:
    2023
  • 资助金额:
    $ 18.5万
  • 项目类别:
Gender and Asthma
性别与哮喘
  • 批准号:
    10583660
  • 财政年份:
    2023
  • 资助金额:
    $ 18.5万
  • 项目类别:
Function and Differentiation
功能与差异化
  • 批准号:
    10886165
  • 财政年份:
    2023
  • 资助金额:
    $ 18.5万
  • 项目类别:
Investigating the mechanisms by which systemic inflammation promotes Alzheimer’s disease: Asthma as a model and modifiable risk factor
研究全身炎症促进阿尔茨海默病的机制:哮喘作为模型和可改变的危险因素
  • 批准号:
    10661382
  • 财政年份:
    2023
  • 资助金额:
    $ 18.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了